TJHMS, Volume 7 Issue 2 (Apr. - June) 2024
Review Articles
TREATMENT OF MEASLES (RUBELOA) WITH A RARE REMEDY MALANDRINUM
Kishan Kumar Brij, Megha, Haobam Vidyalaxmi Devi
Even though a safe and cost-effective vaccine is available, in 2018, there were more than 140 000 measles deaths globally, mostly among children under the age of five. Measles vaccination resulted in a 73% drop in measles deaths between 2000 and 2018 worldwide. In 2018, about 86% of the world's children received one dose of measles vaccine by their first birthday through routine health services – up from 72% in 2000. During 2000- 2018, measles vaccination prevented an estimated 23.2 million deaths making measles vaccine one of the best buys in public health. Malandrinum a (Nosode), commonly "The crust assumed a conical form; a thick layer of crusts, if allowed to remain without removal, heaped up one-half 'an inch. They were fragile, moist, yellow, about the consistency of honey-comb. When removed a raw surface remained with deep fissures and thick crusts reformed into their original size in 48 hours. There was evidently no itching, but some soreness after removal of the scabs."
